Depression in patients with hematologic malignancies: The current landscape and future directions
- 13 February 2024
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 65, 101182
Abstract
No abstract availableKeywords
Funding Information
- Dana-Farber Cancer Institute
This publication has 96 references indexed in Scilit:
- Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysisSupportive Care in Cancer, 2011
- Screening for major depression in cancer outpatientsCancer, 2010
- Hospital anxiety and depression scale cutoff scores for cancer patients in acute careBritish Journal of Cancer, 2009
- Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With CancerJournal of Clinical Oncology, 2008
- Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell TransplantationJournal of Clinical Oncology, 2005
- The PHQ-9Journal of General Internal Medicine, 2001
- An Attempt to Employ the Zung Self-Rating Depression Scale as a “Lab Test” to Trigger Follow-Up in Ambulatory Oncology ClinicsJournal of Pain and Symptom Management, 2001
- The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety InventoriesBehaviour Research and Therapy, 1995
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- The CES-D ScaleApplied Psychological Measurement, 1977